AGP Executive Report
Last update: 16 minutes agoMedical Breakthrough: A Phase 2 LiBBY trial at the Alzheimer’s Association conference reports THC+CBD (2mg THC/100mg CBD twice daily) eased agitation in late-stage dementia—about 84% improved in two weeks and nearly 90% by 12 weeks, with far fewer placebo responders. Policy Push: The UFCW’s cannabis workers’ union backs the Cannabis Administration and Opportunity Act, arguing federal rules should protect workers and repair harms from the War on Drugs. Mental Health Watch: A Journal of Affective Disorders study links cannabis use in young adults at risk for bipolar-spectrum issues to more disruption in daily responsibilities (work/school) rather than simply higher use. Rescheduling Reality Check: A Penn State Q&A says rescheduling to Schedule III recognizes medical value but still leaves state rules in charge, while broader DEA changes remain uncertain. Hemp THC Fight: Florida hemp businesses warn a planned federal ban on intoxicating hemp-derived CBD/THC products (effective Nov. 12) could wipe out most current products, while Missouri’s hemp ban faces a federal lawsuit. Pregnancy Data: UAMS researchers report Arkansas medical-cannabis purchasing patterns during pregnancy, finding 1.62% of pregnancies involved purchases.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
